Matthew Harrison
Stock Analyst at Morgan Stanley
(3.37)
# 859
Out of 4,827 analysts
737
Total ratings
46.45%
Success rate
2.1%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Maintains: Overweight | $182 → $113 | $36.44 | +210.10% | 36 | May 7, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $462 → $464 | $424.66 | +9.26% | 38 | May 6, 2025 | |
| GILD Gilead Sciences | Maintains: Overweight | $130 → $135 | $96.52 | +39.87% | 41 | Apr 25, 2025 | |
| AVIR Atea Pharmaceuticals | Maintains: Equal-Weight | $6.2 → $6 | $2.68 | +124.30% | 10 | Apr 11, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $157 → $152 | $118.02 | +28.79% | 52 | Apr 9, 2025 | |
| MRNA Moderna | Maintains: Equal-Weight | $39 → $32 | $24.29 | +31.74% | 25 | Apr 9, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $82 → $80 | $30.63 | +161.18% | 11 | Mar 17, 2025 | |
| TSVT 2seventy bio | Maintains: Equal-Weight | $6 → $5 | $5.00 | - | 10 | Mar 14, 2025 | |
| TNYA Tenaya Therapeutics | Maintains: Overweight | $15 → $5 | $0.44 | +1,040.25% | 5 | Mar 12, 2025 | |
| DNLI Denali Therapeutics | Assumes: Overweight | $41 → $33 | $14.06 | +134.79% | 12 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $134.30 | +32.54% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $36.75 | +52.38% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $90 | $64.03 | +40.56% | 16 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $34.31 | +60.30% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $0.98 | +207.19% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1,235 → $1,184 | $535.03 | +121.30% | 50 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $4 → $6 | $1.00 | +500.00% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $12.11 | -9.17% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $1.24 | +547.77% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $510 | $540.65 | -5.67% | 24 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $1.37 | +412.82% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $112 | $59.73 | +87.51% | 21 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $17.25 | +97.10% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $19.48 | +64.31% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $1.32 | +1,339.39% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underweight | $60 | $3.79 | +1,481.32% | 30 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $13 | $2.38 | +447.37% | 4 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $0.54 | +85.12% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $18.34 | -45.47% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $5.18 | +54.44% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $25.25 | +74.26% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $1.71 | +660.23% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $4 | $0.42 | +854.54% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5 → $3 | $0.36 | +727.13% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $93.60 | +130.77% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $1.27 | +295.26% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | - | - | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $184.16 | -1.17% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $4.04 | +122.77% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $42.57 | -6.04% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $269.39 | +4.68% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $256.09 | -18.00% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $22.82 | +127.87% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $156.17 | +10.78% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $61 → $57 | $6.86 | +731.51% | 9 | Mar 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $34.51 | +247.73% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $19.48 | +659.75% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $77.60 | +5.67% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $47.05 | +40.28% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $1.93 | +1,920.73% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $33.23 | +38.43% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $8.90 | +293.48% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $742.25 | -62.95% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $1.77 | +973.45% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $6.98 | +788.25% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $15.14 | +13.94% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $50 | $0.90 | +5,455.56% | 4 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $58.79 | +41.18% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $59 → $57 | $29.35 | +94.21% | 4 | Oct 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $31.85 | -68.60% | 4 | Sep 10, 2018 |
Sarepta Therapeutics
May 7, 2025
Maintains: Overweight
Price Target: $182 → $113
Current: $36.44
Upside: +210.10%
Vertex Pharmaceuticals
May 6, 2025
Maintains: Equal-Weight
Price Target: $462 → $464
Current: $424.66
Upside: +9.26%
Gilead Sciences
Apr 25, 2025
Maintains: Overweight
Price Target: $130 → $135
Current: $96.52
Upside: +39.87%
Atea Pharmaceuticals
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $2.68
Upside: +124.30%
Biogen
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $157 → $152
Current: $118.02
Upside: +28.79%
Moderna
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $39 → $32
Current: $24.29
Upside: +31.74%
Legend Biotech
Mar 17, 2025
Maintains: Overweight
Price Target: $82 → $80
Current: $30.63
Upside: +161.18%
2seventy bio
Mar 14, 2025
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $5.00
Upside: -
Tenaya Therapeutics
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.44
Upside: +1,040.25%
Denali Therapeutics
Mar 7, 2025
Assumes: Overweight
Price Target: $41 → $33
Current: $14.06
Upside: +134.79%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $134.30
Upside: +32.54%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $36.75
Upside: +52.38%
Feb 6, 2025
Maintains: Overweight
Price Target: $85 → $90
Current: $64.03
Upside: +40.56%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $34.31
Upside: +60.30%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $0.98
Upside: +207.19%
Nov 1, 2024
Maintains: Overweight
Price Target: $1,235 → $1,184
Current: $535.03
Upside: +121.30%
Sep 16, 2024
Maintains: Overweight
Price Target: $4 → $6
Current: $1.00
Upside: +500.00%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $12.11
Upside: -9.17%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $1.24
Upside: +547.77%
May 28, 2024
Maintains: Overweight
Price Target: $515 → $510
Current: $540.65
Upside: -5.67%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $1.37
Upside: +412.82%
Apr 26, 2024
Maintains: Overweight
Price Target: $115 → $112
Current: $59.73
Upside: +87.51%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $17.25
Upside: +97.10%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $19.48
Upside: +64.31%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $1.32
Upside: +1,339.39%
Jul 11, 2023
Reiterates: Underweight
Price Target: $60
Current: $3.79
Upside: +1,481.32%
Mar 27, 2023
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $2.38
Upside: +447.37%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $0.54
Upside: +85.12%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $18.34
Upside: -45.47%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $5.18
Upside: +54.44%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $25.25
Upside: +74.26%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $1.71
Upside: +660.23%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $4
Current: $0.42
Upside: +854.54%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $5 → $3
Current: $0.36
Upside: +727.13%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $93.60
Upside: +130.77%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $1.27
Upside: +295.26%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: -
Upside: -
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $184.16
Upside: -1.17%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $4.04
Upside: +122.77%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $42.57
Upside: -6.04%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $269.39
Upside: +4.68%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $256.09
Upside: -18.00%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $22.82
Upside: +127.87%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $156.17
Upside: +10.78%
Mar 10, 2022
Maintains: Equal-Weight
Price Target: $61 → $57
Current: $6.86
Upside: +731.51%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $34.51
Upside: +247.73%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $19.48
Upside: +659.75%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $77.60
Upside: +5.67%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $47.05
Upside: +40.28%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $1.93
Upside: +1,920.73%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $33.23
Upside: +38.43%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $8.90
Upside: +293.48%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $742.25
Upside: -62.95%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $1.77
Upside: +973.45%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $6.98
Upside: +788.25%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $15.14
Upside: +13.94%
Aug 18, 2020
Downgrades: Equal-Weight
Price Target: $50
Current: $0.90
Upside: +5,455.56%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $58.79
Upside: +41.18%
Oct 11, 2018
Maintains: Overweight
Price Target: $59 → $57
Current: $29.35
Upside: +94.21%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $31.85
Upside: -68.60%